🇺🇸 FDA

Company profile · Sponsor

Petros

Petros Pharmaceuticals

PTPI · NYSE pharma NEW YORK, NY, USA
Pipeline
3
Drugs
0
Patents
0

Quick answer

Petros (PTPI) is a pharma company. headquartered in NEW YORK, NY, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker PTPI
Exchange NYSE
Company type pharma
Headquarters NEW YORK, NY, USA
SEC CIK 0001815903

Pipeline (3)

Search pipeline →

  1. Colostrum supplementation for bone loss

    Petros

    Osteopenia

    other completed

    1 trial

  2. Neutral environment with radiation

    Petros

    Heat Stress

    other completed

    1 trial

  3. Thermal stress and performance without a pre-cooling protocol

    Petros

    Risk of Heat Stress

    mab completed

    1 trial

Frequently asked questions

What is Petros?

Petros (PTPI) is a pharma company. headquartered in NEW YORK, NY, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Petros sponsor?

We track 3 ClinicalTrials.gov-linked programs for Petros, including Colostrum supplementation for bone loss and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Petros company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.